Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar

Thread starter U.S. News
Start date Feb 5, 2026

U.S. News

Guest

Feb 5, 2026

Eli Lilly's full-year guidance comes in stark contrast to the outlook of Novo Nordisk, which warned it sees sales and profit declining as much as 13% this year.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar

Prefix: N/A

Forum: USA News

Start date: Feb 5, 2026

Last reply date: Feb 5, 2026

Replies: 0

Thread Tags

Thread statistics

Created: U.S. News, Feb 5, 2026

Replies: 0

Views: 1

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search